News
Press Release: New Innovation Makes Coronavirus Rapid Testing More Accurate than Laboratory Tests
Turku, March 28, 2024 - The Finnish infectious disease diagnostics device manufacturer, ArcDia Oy, has...
Press release: New scientific reports demonstrate the high accuracy of mariPOC COVID-19 tests in decentralized testing
Turku, Finland, October 24th, 2022 – the Finnish medical device manufacturer ArcDia International Ltd reports...
Nasal sampling and EU RAT list
Nasal sampling and self-sampling with mariPOC During the COVID-19 pandemic, the suitability of nasal sampling...
mariPOC COVID-19 tests are suitable for travel certificates in the EU
The use of the mariPOC SARS-CoV-2, Respi+ and Quick Flu+ tests for EU COVID certificates...
Press release: ArcDia launches a quick and automated COVID-19 antigen test with superior performance
Turku, Finland, March 3rd, 2021 – the Finnish medical device manufacturer ArcDia International Ltd has...
Press release: Bruker to distribute ArcDia’s mariPOC® products for automated antigen POCT of COVID-19 and other infectious diseases in Central Europe
Turku, September 10th 2020 – ArcDia International Oy Ltd (“ArcDia”), developer and manufacturer of the...
Press release: ArcDia Ltd’s automated coronavirus point-of-care test CE marked and available
Turku Finland, May 25, 2020 – the Finnish medical device manufacturer ArcDia International Ltd has...
Press Release: ArcDia Ltd reports a breakthrough in the development of an automated coronavirus point-of-care test
Turku Finland, April 27, 2020 – the Finnish medical device manufacturer ArcDia International Ltd reports...
Press Release: ArcDia’s products would allow testing of all respiratory tract and COVID-19 patients in Finland
Turku Finland, March 26, 2020 – the Finnish medical device manufacturer ArcDia International Ltd reports...
Press Release: ArcDia International Ltd develops a COVID-19 test for primary care
Turku Finland, March 11, 2020 – the Finnish medical device manufacturer ArcDia International Ltd develops...
Pathogen Detection in Perianal Streptococcal Dermatitis
ArcDia International Ltd is pleased to announce that perianal streptococcal dermatitis has been added as...
Mr. Vesa Kemppainen appointed as the new CEO
Mr. Vesa Kemppainen has been appointed as the CEO of ArcDia International Ltd as of...
New mariPOC® publication: Evaluation of a Gastrointestinal Pathogen Panel Immunoassay in Stool Testing of Patients with Suspected Clostridioides (Clostridium) difficile Infection.
Krutova M, et al. (2019) J Clin Microbiol. 57(10) e00710-19 Full article
New mariPOC® publication: Comparison of phenotypic and genotypic diagnosis of acute human bocavirus 1 infection in children.
Kols NI, et al. (2019) J Clin Virol. 120:17-19 Full article
ArcDia has entered into an exclusive license agreement with Xinhua Healthcare for the commercialisation of ArcDia’s mariPOC® technology in China
Turku, 9th April 2019 – Today, ArcDia International Oy Ltd, manufacturer of the successful mariPOC®...
mariPOC® ensures lower probability for C. difficile misdiagnosis with precision
mariPOC® ensures lower probability for C. difficile misdiagnosis with precision mariPOC® CDI test is a...
New research data shows that influenza antigen testing correlates best with the infectivity period
A recent study by Inagaki et al. in The Journal of Infectious Diseases shows that,...
Press release: New test for detection of C. difficile infection
Turku Finland, 11/1/2017 – Today, the Finnish medical device manufacturer ArcDia International Ltd launches a new IVD test...
New QuickStrepA
ArcDia has updated the mariPOC® test for tonsillitis. The new QuickStrepA test reports final result already in 15 min. The...
Study: Diagnosis of respiratory tract infections caused by human bocavirus 1
Human bocavirus 1 (HBoV1) causes respiratory tract infections in infants and children. Diagnosis of acute...
New mariPOC influenza A virus test with significantly improved sensitivity
mariPOC® is present in Virology Days in Jyväskylä 14-15.3.2017. Petri Antikainen from ArcDia gives an...
New test for Flu A
The influenza A virus test of mariPOC® respi has been updated. It is now 10-30%...
World’s fastest antibiotic resistance testing
ArcDia’s groundbreaking technology enables world’s fastest phenotypic antibiotic resistance testing Turku, June 8, 2016 –...
New mariPOC® Gastro test available
ArcDia International Oy Ltd. has launched a new product line for rapid diagnostics of acute...
Detection and monitoring of human bocavirus 1 infection by a new rapid antigen test
Clinically relevant diagnosis of human bocavirus 1 (HBoV1) is challenging, as the virus is frequently...
ArcDia contributes solving the global problem of antimicrobial resistance
mariPOC by ArcDia is taking part in the Longitud Prize competition which aims to develop...
Press release: Spanish clinical study demonstrates mariPOC’s excellent performance
A recent study demonstrates that treatment of influenza-like illnesses can be significantly improved by using...
ArcDia is developing pandemics preparedness
ArcDia has signed an agreement to develop diagnostic system to increse pandemic preparedness. The R&D...
The diagnostics of group A streptococcus from pharyngeal swab samples by bacterial culture is challenged by a novel mariPOC point of care test.
Journal of Clinical Microbiology has published the study about point of care testing of group...
The Flu Season Has Begun – mariPOC® Helps
Flu is one of the most common reasons for sick leaves from work, school or...
Nobel Prize awarded to mariPOC® sister technology
The year 2014 Nobel Prize in Chemistry has been awarded to a Professor Stefan W....
The Evolution of Rapid POC Tests for Infectious Disease Diagnostics: An Exclusive SelectScience Interview
Earlier this year, Frost & Sullivan, the global research organization, awarded ArcDia the European Respiratory...
ArcDia Receives Frost & Sullivan Award for Point-of-Care Product Leadership!
Frost & Sullivan has recognized mariPOC® as the leading product in rapid diagnostics testing of...
ArcDia launches world’s first antigen test for human bocavirus – Press Release
ArcDia launches world’s first antigen test for human bocavirus - Press Release pdf
New press release
ArcDia has expanded its distributor and service network to cover 16 countries in Europe and...